« Previous
Next »
Transplantation Proceedings
Volume 35, Issue 6
, Pages 2080-2081
, September 2003
Daily interferon Alpha-2B and ribavirin combination therapy for liver transplant patients with chronic hepatitis C infection
☆ This work was supported by Essex Pharma GmbH, München, Germany.
PII: S0041-1345(03)00681-X
doi: 10.1016/S0041-1345(03)00681-X
© 2003 Elsevier Science Inc. All rights reserved.
« Previous
Next »
Transplantation Proceedings
Volume 35, Issue 6
, Pages 2080-2081
, September 2003
